Related Experiment Video

Updated: May 22, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Is Myocardial Infarction in Patients without Significant Stenosis on a Coronary Angiogram as Benign as Believed?

Shi Hyun Rhew1, Youngkeun Ahn, Min Chul Kim

  • 1Department of Cardiology, Chonnam National University Hospital, Gwangju, Korea.

Chonnam Medical Journal
|May 10, 2012
PubMed

Insights

Patients with acute myocardial infarction (AMI) but without significant coronary artery stenosis had similar 1-year outcomes to those with stenosis. This finding holds true even when analyzing subgroups with cryptogenic causes versus identifiable factors.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Acute myocardial infarction (AMI) patients without significant coronary artery stenosis represent a distinct clinical subgroup.
  • Understanding the characteristics and outcomes of this group is crucial for refining diagnostic and therapeutic strategies.
  • Comparison with AMI patients exhibiting significant coronary artery stenosis provides valuable insights into disease heterogeneity.

Purpose of the Study:

  • To investigate the clinical characteristics of AMI patients without significant coronary artery stenosis.
  • To compare the 1-year outcomes of AMI patients with and without significant coronary artery stenosis.
  • To analyze outcomes within subgroups of non-significant stenosis based on underlying etiology.

Main Methods:

  • Retrospective analysis of 1,220 AMI patients.
  • Classification into Group I (≥50% diameter stenosis) and Group II (<50% diameter stenosis).
  • Subgrouping of Group II into cryptogenic (II-a) and possible causative factors (II-b), including vasospasm, myocardial bridge, and spontaneous thrombolysis.

Main Results:

  • Group II patients were younger, more often women, and less likely to smoke or have diabetes compared to Group I.
  • Major adverse cardiac events (MACE) rates at 1 and 12 months were not significantly different between Group I and Group II.
  • Clinical outcomes, including MACE and mortality at 12 months, were similar between Group II-a and Group II-b, despite differences in NT-proBNP and hs-CRP levels.

Conclusions:

  • AMI patients without significant coronary artery stenosis demonstrate comparable 1-year clinical outcomes to those with significant stenosis.
  • Subgroup analysis reveals similar clinical outcomes between cryptogenic and identifiable causes of non-significant stenosis AMI.
  • The findings suggest that non-obstructive coronary artery disease in AMI does not necessarily portend a worse prognosis.

Keywords:
Coronary angiographyMyocardial infarctionStenosis

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Related Concept Videos

Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...